09:10 AM EDT, 10/09/2024 (MT Newswires) -- NanoVibronix ( NAOV ) said Wednesday that it signed a non-binding term sheet for a license and supply agreement with Apogepha Arzneimittel for its UroShield urology therapy device.

The company said it and the German pharmaceutical company plan to enter into a definitive agreement under which Apogepha will distribute UroShield throughout Europe.

Financial terms were not disclosed.

The ultrasound-based product reduces catheter-associated urinary tract infections and decreases the pain and of urinary catheter use, the company said.